Back to top

AMENDMENT NO. 1 TO JJCC INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT

IP Intellectual Property License Assignment Agreement

AMENDMENT NO. 1 TO JJCC INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT | Document Parties: BARRIER THERAPEUTICS INC | Johnson & Johnson Consumer Companies, Inc | Barrier Therapeutics, Inc | Barrier and Janssen Pharmaceutica Products, L.P You are currently viewing:
This IP Intellectual Property License Assignment Agreement involves

BARRIER THERAPEUTICS INC | Johnson & Johnson Consumer Companies, Inc | Barrier Therapeutics, Inc | Barrier and Janssen Pharmaceutica Products, L.P

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: AMENDMENT NO. 1 TO JJCC INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT
Governing Law: New York     Date: 9/10/2004

AMENDMENT NO. 1 TO JJCC INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT, Parties: barrier therapeutics inc , johnson & johnson consumer companies  inc , barrier therapeutics  inc , barrier and janssen pharmaceutica products  l.p
50 of the Top 250 law firms use our Products every day
 

Exhibit 10.1

AMENDMENT NO. 1 TO JJCC INTELLECTUAL PROPERTY TRANSFER AND LICENSE AGREEMENT

This Amendment No. 1 (the “JJCC Amendment”) is made and entered into as of September 7, 2004 by and between Johnson & Johnson Consumer Companies, Inc., a New Jersey corporation having an address at 199 Grandview Road, Skillman, New Jersey 08558 (hereinafter referred to as “JJCC”) and Barrier Therapeutics, Inc., a Delaware corporation having an address at 600 College Road East, Suite 3200, Princeton, New Jersey 08540 (hereinafter referred to as “Barrier”).

WHEREAS, JJCC and Barrier are parties to that certain Intellectual Property Transfer and License Agreement dated May 6, 2002 (the “Original JJCC Agreement”);

WHEREAS, JJCC and Barrier desire to make certain amendments to the Original JJCC Agreement pursuant to the terms of this JJCC Amendment; and

WHEREAS, contemporaneously with the execution and delivery hereof, Barrier and Janssen Pharmaceutica Products, L.P., an Affiliate of JJCC (“Janssen”), are entering into an amendment to that certain Intellectual Property Transfer and License Agreement between Barrier and Janssen dated May 6, 2002.

NOW, THEREFORE, in consideration of the above premises and the covenants contained herein, the parties agree as follows:

1.

 

The Original JJCC Agreement is hereby amended as follows:

 

 

1.1.

 

The definition of “JJCC Countries” in Section 1.15 of the Original JJCC Agreement is hereby replaced in its entirety with the following:

          “JJCC Countries shall mean Argentina, Australia, Belgium, Denmark, Germany, Indonesia, Luxembourg, Mexico, New Zealand, Pakistan, Peru and Venezuela.”

 

1.2.

 

Section 2.1 of the Original JJCC Agreement is hereby replaced in its entirety with the following:

          “Subject to Section 2.2, JJCC hereby grants to Barrier the exclusive (even as to JJCC and its Affiliates), royalty-free license with the unrestricted right to grant sublicenses (subject to Section 2.6 and Article 5), under the ‘932 Patent Rights to (i) import, use, sell, offer for sale, and have sold ‘932 Products in the ‘932 Territory and (ii) make and have made ‘932 Products anywhere in the world in order to import, use, sell, offer for sale, and have sold ‘932 Products in the ‘932 Territory. JJCC hereby grants to Barrier (i) the Semi-exclusive (along with JJCC and its Affili


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more